Dosage Flashcards
ABIXIMAB
dosage
Adult Dosage: Based on the EPILOG (NEJM. 1997; 336: 1689) and CAPTURE (Lancet. 1997; 349: 1429) studies:
Loading Dose: 0.25mg/kg IV over 5 minutes slow IV push
Infusion: 0.125mcg/kg/min (0.09mg/kg) if patient less than 80kg
10mcg/min (7.2mg) if patient equal to or greater than 80kg
in 250ml D5W or NS at 21ml/hr for 12 hours
Pediatric Dosage: Safety and efficacy in children have not been established.
ACETYLSALICYLIC ACID, ASPIRIN, ASA
dosage
Adult Dosage:
- Cardiac: 160- 325 mg (2-4 pediatric chewable tabs), chew or swallow
- Pain/discomfort/fever: 325 mg po (4 pediatric chewable tablets), chew or swallow
Pediatric Dosage:
Not recommended for prehospital use in children
ACETYLSALICYLIC ACID, ASPIRIN, ASA (EMT Administration)
dosage
Adult Dosage:
Cardiac: 160-325 mg (2-4 81 mg tabs), chew or swallow
Pediatric Dosage:
Not recommended for prehospital use in children
ADENOSINE
dosage
Adult Dosage:
- Initial: 6 mg rapid IV bolus over 1-3 seconds
- Special administration procedure: Follow immediately with 20 ml normal saline flush.
IV site recommended is antecubital fossa (close to central circulation); use injection port
nearest hub of IV catheter; arm elevated during procedure; constant ECG monitoring.
- Repeat: If no response in 1-2 minutes (of each dose, respectively) may repeat 12 mg
utilizing the same procedure for the repeat dose.
Pediatric Dosage: (Drug of choice for treating SVT in symptomatic infants and children)
- Initial: 0.1 mg/kg as a rapid IV bolus.
- Special administration procedure: Follow immediately with 2-3 ml normal saline flush.
Use injection port nearest the hub of IV catheter for procedure; constant ECG monitoring.
- Repeat: If no response, dose may be doubled 1 time (0.2 mg/kg) using same
administration procedure.
- Maximum single dose: Should not exceed 12 mg.
- Infants with SVT associated with shock: Adenosine may precede cardioversion if vascular access is available, but cardioversion should not be delayed while IV access is achieved.
ALBUMIN, normal serum 5% / 25%
dosage
Dosage:
Adult: IV 500 ml of 5% sol Q30 min, as needed
Child: 1⁄4 - 1⁄2 adult dose in non-emergencies
ALUTEROL SULFATE
dosage
Adult Dosage:
Give 2.5 mg of premixed solution for inhalation (0.083%) via SVN with a mouth piece, or in-line with a ventilatory device. Repeated according to medical control preference.
Pediatric Dosage: (children <40 lbs)
Give 2.5 mg of premixed solution for inhalation (0.083%) via SVN with a mouth piece, mask, or in-line with a ventilatory device. Repeated according to medical control preference.
May administer up to 5mg per dose according to medical control preference.
AMIODARONE
dosage
Adult Dosage:
VF/Pulseless VT:
300 mg IV push over 30 – 60 seconds, may repeat in 3-5 minutes with 150 mg IV push
Wide-Complex Tachycardias, Atrial Flutter, Atrial Fibrillation, SVT with cardioversion:
150 mg IV over 10 minutes (mix in 50 mL bag of D5W) may repeat every 10 minutes
Maintenance Infusion Post Resuscitation/Conversion:
After successful defibrillation, follow with up to 1mg/min IV infusion for 6 hours, then up to 0.5 mg/min IV infusion for up to 18 hours, maximum daily dose is 2.2 grams
Mix 450 mg in 250 mL of D5W (special polyolefin bag), concentration 1.8 mg/mL, and run at 33.3 mL/hr for 1 mg/min or 16.7 mL/hr for 0.5 mg/min
For Other Maintenance infusion:
Rates range from 0.5 mg/min to 1mg/min. Maximum daily dose is 2.2 grams
Pediatric Dosage:
VF/Pulseless VT:
5 mg/kg IV push (max 300 mg single dose), may repeat every 5 minutes two times to a total maximum of 15 mg/kg/day
Probable VT with pulse:
5 mg/kg IV administered over 20 minutes may repeat two more times to a total of 15 mg/kg/day
ATROPINE SULFATE
dosage
Adult Dosage:
Special instructions
- IV/IO – administer undiluted by rapid IV injection; slow injection may result in paradoxical bradycardia. Doses < 0.5 mg may increase vagal tone resulting in paradoxical bradycardia.
- IM – AtroPen should be administered to outer thigh. May be given through clothing as long as pockets at injection site are clear. Hold autoinjector in place for 10 seconds following injection; massage injection site.
Symptomatic Bradycardia:
- IV/IO – 0.5 mg every 5 minutes. Do NOT exceed a total dose of 3 mg or 0.04mg/kg if symptoms profound.
- Consider atropine before pacing in mildly symptomatic patients, but do not delay
pacing in unstable patients, particularly those with high-degree AV block
- Do not rely on atropine in Mobitz type II second or third-degree AV block or in
patients with third-degree AV block with a new wide QRS complex. Hemodynamically unstable and clinically deteriorating patients require immediate pacing.
Organophosphate or carbamate poisoning:
- IV/IO – Initially: 1-5 mg. Doses should be doubled every 5 minutes until signs of
muscarinic excess abate (clearing of bronchial secretions, bronchospasm, and adequate
oxygenation)
- IV infusion – 0.5-1 mg/hour or 10-20% of loading dose/hour
- IM – (AtroPen) mild symptoms: Administer 2 mg as soon as exposure is known or
suspected. If severe symptoms develop after first dose, 2 additional doses should be repeated in 10 minutes, not to exceed more than 3 doses. Severe symptoms: Immediately administer three 2 mg doses.
Pediatric Dosage:
Symptomatic Bradycardia:
- IV/IO – 0.02 mg/kg (minimum of 0.1 mg), may repeat at 5 minute intervals to a
maximum total dose of 1 mg in children and 2 mg in adolescents
- Maximum single doses: Child 0.5 mg; Adolescent 1 mg.
For bradycardia in neonates, reserve use for those unresponsive to improved oxygenation and epinephrine.
Organophosphate or carbamate cholinergic poisoning:
- IV/IO – 0.03-0.05 mg/kg every 10 to 20 minutes until cholinergic symptoms minimize,
then every 1 to 4 hours for at least 24 hours
- IM – Administer dose as listed below as soon as exposure is known or suspected. If
sever symptoms develop after first dose, 2 additional doses should be repeated in 10 minutes.
Do not administer more than 3 doses. For severe symptoms, immediately administer 3 doses as follows:
- < 6.8 kg (15 lbs): not recommended, administer atropine 0.05 mg/kg o 6.8-18 kg (15-40 lbs): 0.5 mg/dose
- 18-41 kg (40-90 lbs): 1mg/dose
- 41 kg (> 90 lbs): 2mg/dose
BUMETANIDE
dosage
Adult Dosage:
0.5 to 1.0 mg IV slowly over 1 to 2 minutes, or IM
CALCIUM CHLORIDE
dosage
Adult Dosage:
Hypocalcemia, calcium channel blocker OD, hyperkalemia and hypermagnesemia:
5-10 ml (0.5-1 Gm) of 10% calcium chloride. May repeat in 10 minutes.
Pre-treatment for IV calcium channel blocker administration: 3 ml of 10% calcium chloride. May be repeated once.
Pediatric Dosage:
Hypocalcemia, calcium channel blocker OD hyperkalemia and hypermagnesemia:
0.2 - 0.25 ml/kg of a 10% solution infused slowly. Should not be repeated without documented calcium deficiency.
CALCIUM GLUCONATE GEL, 2.5%
dosage
Dosage: Adult and Pediatric
If hydrofluoric acid contacts the body, it is highly recommended to wash/flush the area with tepid water for at least 3 minutes to remove HF surface residue.
Apply calcium gluconate gel freely to the affected areas and continuously massage into the skin. May reapply gel every 15 minutes until arrival at hospital.
CHARCOAL, ACTIVATED (without sorbitol)
dosage
Adult Dosage:
30-60 Gm (1-2 Gm/kg); if not in pre-mixed slurry, mix one part charcoal with four parts water.
Pediatric Dosage:
0.5 -1.0 Gm/kg; if not in pre-mixed slurry, mix one part charcoal with four parts water.
CIMETIDINE
dosage
Adult Dosage:
- Pathologic hypersecretory conditions: 300mg in 50 mL normal saline infuse over 30 minutes
- Prevention of upper GI bleeding: 50 mg/hour continuous infusion
Pediatric Dosage:
Can be utilized in children 16 years or older
DEXAMETHASONE SODIUM PHOSPHATE
dosage
Adult Dosage:
Reactive Airway Disease, Anaphylaxis: 8-24 mg
Cerebral Edema: 1-5 mg/kg
Pediatric Dosage:
Reactive Airway Disease, Anaphylaxis: 0.25-0.5 mg/kg
Cerebral Edema: 0.5-1.5 mg/kg
DEXTROSE 50%
dosage
Adult Dosage:
Hypoglycemia, altered level of consciousness or seizures of unknown etiology: 25- 100 ml of D50 (12.5-50 Gm, 1/2 to 2 amps) IV.
Hyperkalemia: 50 Gm of Dextrose IV administered in conjunction with calcium chloride and sodium bicarbonate. Insulin may be given upon arrival to ED.
Pediatric Dosage: (14 yrs and below includes infant)
- Administer 0.5 - 1 Gm/kg of a dextrose 10% solution; recommended to give slowly over a 20 minute period.
- Dilute D50 (dextrose 50% containing 25 Gm of dextrose) to a 1:4 solution. To prepare, obtain a 250 ml container of normal saline for IV use; waste 50 ml and add 50 ml of dextrose 50%. The resulting solution is dextrose 10% in normal saline or 10 grams/100ml.
DIAZEPAM
dosage
Adult Dosage:
2 mg increments slow IV push. Administer no faster than 2 mg/minute.
Pediatric Dosage:
IV Dose: 0.2-0.3 mg/kg every 15-30 minutes (max. of 1.0 mg/kg); administer IV over at least 3 minutes or until seizure activity subsides.
IV Dose after rectal dose: 0.1 mg/kg with same administration instructions.
Rectal dose (less than or equal to 6 years): 0.3-0.5 mg/kg rectally at IV push rate; may repeat in 15-30 min at 0.25 mg/kg.
DILTIAZEM
dosage
Adult Dosage:
Initial: 0.25 mg/kg IVP (usually 20 mg) administered over 2 minutes
If response is inadequate, repeat in 15 minutes: 0.35 mg/kg IVP administered over 2 mins Maintenance infusion:5.0 to 15 mg/hr
Pediatric Dosage:
The safety and efficacy of this drug for use in children has not been established.
DIPHENHYDRAMINE HCL
dosage
Adult Dosage:
Anaphylaxis: 25-50 mg slow IV push or deep IM.
Extrapyramidal symptoms and antiemetic: 10-50 mg IV or deep IM, dose should be individualized according to the needs and patient response.
Pediatric Dosage:
1.0 -1.25 mg/kg slow IV push May also be given deep IM
DOPAMINE
dosage
Adult Dosage: (dosage range 2-20 mcg/kg/min)
Preparation: (If premixed not carried) Add 400 mg/ 250 ml NS or Dextrose = 1600 mcg/ml.
Bradycardia: Start at 5 mcg/kg/min
Shock: cardiogenic or septic (non-hypovolemic)
BP < 70 systolic: Start drip at 5 mcg/kg/min
BP > 70 systolic: Start drip at 2.5 mcg/kg/min
Pediatric Dosage:
2-20 mcg/kg/min for circulatory shock or shock unresponsive to fluid administration. To prepare infusion for small children: 6 x body wt. in kg = mg added to NS to make 100 ml. With this mixture 1 ml/hr delivers 1 mc/kg/min; titrate to effect.
EPINEPHRINE AUTO-INJECTOR
dosage
Adult Dosage:
Intramuscular: 0.3 mg (one adult auto-injector)
Pediatric Dosage:
Intramuscular: 0.15 mg (one pediatric auto-injector), for patients less than or equal to 30 kg (66 lbs) body weight
Intramuscular: 0.3 mg (one adult auto-injector) for patients >30 kg (66 lbs) body weight
EPINEPHRINE HCL
dosage
Adult Dosage:
Pulseless Arrest –
IV/IO: 1 mg of 1:10,000 solution repeat every 3 - 5 minutes or,
ET: Give 2 - 2.5 mg via the ET tube.
May use 1:10,000 or dilute 1:1000 to equal 10 mL via ET tube for adult. (i.e., 2 mg of 1:1,000 epinephrine diluted with 8 mL NS in a 10 mL syringe)
Continuous Infusion for Hypotension or Symptomatic Bradycardia: 1 mg added to 500 mL of NS administered at 1 mcg/min titrated to desired hemodynamic response (range 2-10 mcg/min); not first-line therapy.
Anaphylaxis and asthma: Give 0.3 - 0.5 mg of 1:1,000 solution IM (preferred), SC, or inject SL, may repeat every 15 to 20 minutes; or in extreme cases only, may be asked to use 1:10,000 solution and give 0.1 mg every 5 minutes IV/IO or continuous IV/IO infusion of 1 - 4 mcg/min to prevent need for multiple injections.
Pediatric Dosage:
Pulseless Arrest or Refractory Bradycardia:
IV/IO: 0.01 mg/kg of 1:10,000 repeat every 3 - 5 minutes, maximum single dose 1 mg.
ET: 0.1 mg/kg of 1:1,000; diluted with NS to a volume of 3 - 5 mL prior to instillation or followed with flush of 3 - 5 mL of NS after instillation repeat every 3 - 5 minutes, maximum single dose 10 mg.
Asthma/anaphylaxis: Use 1:1,000 solution; give 0.01 mg/kg IM (preferred), SC (maximum single dose of 0.5 mg/dose).
IV Infusion: 0.1 – 1 mcg/kg/min; to prepare for small children 0. 6 x body wt. in kg = mg added to NS to make 100 mL. With this mixture, 1 mL/hr delivers 0.1 mcg/kg/min.
Croup: 3 mg 1:1,000 mixed in 3 mL NS via SVN.
Neonatal Dose for First 12 hours of life:
IV/IO Initial and Repeat Dose for Cardiac Arrest or Refractory Bradycardia: 0.01- 0.03 mg/kg of 1:10,000 every 3-5 minutes
ET: 0.1 mg/kg of 1:10,000 every 3 – 5 minutes if neonate has no vascular access, fails to respond to positive pressure ventilation with 100% O2.
EPTIFIBATIDE
dosage
Adult Dosage:
Acute Coronary Syndrome: Standard Orders based on the PURSUIT trial: (N Engl J Med. May 21, 1998; 339: 436-43.)
Loading Dose: 180mcg/kg
Infusion: 2.0mcg/kg/minute for 72 hours, until discharge or if angioplasty or CABG
procedure then 20 to 24 hours post procedure (total 96 hours).
Percutaneous Coronary Intervention in patients not presenting with an acute coronary syndrome: Standard Orders based on the IMPACT-II trial: (Lancet. 1997; 349-28)
Loading Dose:135mcg/kg immediately prior to PTCA
Infusion: 0.5mcg/kg/minute, following loading dose and continued for 20-24 hours.
Pediatric Dosage:
Safety and efficacy in children have not been established.